Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid Neoplasms. Leukemia 36(7):1720–1748. https://doi.org/10.1038/s41375-022-01620-2

Shimada K, Hayakawa F, Kiyoi H (2018) Biology and management of primary effusion lymphoma. Blood 132(18):1879–1888. https://doi.org/10.1182/blood-2018-03-791426

Article  CAS  PubMed  Google Scholar 

Kaji D, Ota Y, Sato Y, Nagafuji K, Ueda Y, Okamoto M, Terasaki Y, Tsuyama N, Matsue K, Kinoshita T, Yamamoto G, Taniguchi S, Chiba S, Ohshima K, Izutsu K (2020) Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv 4(18):4442–4450. https://doi.org/10.1182/bloodadvances.2020002293

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d’Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood 140(11):1229–1253. https://doi.org/10.1182/blood.2022015851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimada K, Hayakawa F, Kiyoi H (2018) Biology and management of primary effusion lymphoma. Blood 132(18):1879–1888. https://doi.org/10.1182/blood-2018-03-791426

Article  CAS  PubMed  Google Scholar 

Shin J, Lee JO, Choe JY, Bang SM, Lee JS (2017) Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma in an elderly Korean patient with a good response to rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone. Cancer Res Treat 49(1):274–278. https://doi.org/10.4143/crt.2016.076

Article  PubMed  Google Scholar 

Gisriel SD, Yuan J, Braunberger RC, Maracaja DLV, Chen X, Wu X, McCracken J, Chen M, Xie Y, Brown LE, Li P, Zhou Y, Sethi T, McHenry A, Hauser RG, Paulson N, Tang H, Hsi ED, Wang E, Zhang QY, Young KH, Xu ML, Pan Z (2022) Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics. Mod Pathol 35(10):1411–1422. https://doi.org/10.1038/s41379-022-01091-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kubota T, Sasaki Y, Shiozawa E, Takimoto M, Hishima T, Chong JM (2018) Age and CD20 expression are significant prognostic factors in human herpes virus-8-negative effusion-based lymphoma. Am J Surg Pathol 42(12):1607–1616. https://doi.org/10.1097/PAS.0000000000001168

Article  PubMed  Google Scholar 

Mendeville M, Roemer MGM, van den Hout MFCM, Los-de Vries GT, Bladergroen R, Stathi P, Hijmering NJ, Rosenwald A, Ylstra B, de Jong D (2019) Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood 133(4):377–380. https://doi.org/10.1182/blood-2017-12-822171

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Zhou D, Wang L, Zhu L, Ye X (2022) MYD88 L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy. Ther Adv Hematol 13:20406207211072840. https://doi.org/10.1177/20406207211072839

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM (2018) Genetics and pathogenesis of diffuse large b-cell lymphoma. N Engl J Med 378(15):1396–1407. https://www.nejm.org/doi/https://doi.org/10.1056/NEJMoa1801445

Bitar C, Hile G, Brown NA, Fullen DR, Lowe L, Tejasvi T, Wilcox RA, Harms PW, Chan MP, Bresler SC, Hristov AC (2021) Immunophenotypic switch in cutaneous t-cell lymphoma: a series of three cases and review of the literature. J Cutan Pathol 48(7):986–994. https://doi.org/10.1111/cup.14026

Article  PubMed  Google Scholar